Registered Rwanda · Rwanda FDA

AGOSCAB

Benzyl Benzoate Application BP 25% W/V

Rwanda FDA-HMP-MA-0630 Emulsion 25% W/V various INN generic

What it does

Application is used to treat various skin conditions by applying it directly to the affected area.

Commonly used for: skin infections, eczema, psoriasis

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
Rwanda FDA-HMP-MA-0630
Registration date
10/12/2023
Expiry date
09/12/2028
Status
Registered
Active ingredient
Benzyl Benzoate Application BP 25% W/V
Dosage form
Emulsion
Strength
25% W/V
Pack size
100 ml Bottle
Therapeutic class
-
ATC class (WHO)
V04CG - Tests for gastric secretion
Drug group
VARIOUS
RxNorm RxCUI
70589
Manufacturer / MAH
Agog Pharma
Applicant / LTR
AGOG PHARMA LTD, INDIA
Country of origin
INDIA
Manufacturer location
33, Gaonraipada Sector 2,The Taluka Ind. co. op. estate, Vasai, Sector 2, Golani Naka, Vasai East, Vasai-Virar, Maharashtra 401208, India

Source: Rwanda Food and Drugs Authority · fetched 2026-03-11 22:07:26 · updated 2026-09-21 02:30:20

Disclaimer: This information is sourced from Rwanda Food and Drugs Authority (Rwanda). Always consult a qualified healthcare professional before using any medication.

About application

Application is used to treat various skin conditions by applying it directly to the affected area.

What it treats

  • skin infections
  • eczema
  • psoriasis

How it works

It helps to reduce inflammation and irritation on the skin.

Who it's for

This treatment is suitable for people with specific skin issues as directed by a healthcare provider.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About benzoate

Benzoate is a compound often used as a preservative in food and medicines.

What it treats

  • food preservation
  • medicinal uses in certain formulations

How it works

Benzoate helps prevent the growth of harmful bacteria and fungi, keeping products safe for longer.

Who it's for

People consuming products containing benzoate, including children and adults.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About benzyl

Benzyl is an ingredient used in various treatments, often in topical formulations.

What it treats

  • skin infections
  • eczema
  • scabies

How it works

Benzyl helps to kill bacteria or parasites on the skin, promoting healing.

Who it's for

This treatment is for individuals with skin conditions requiring antibacterial or antiparasitic action.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: application

Application refers to the use of a medication or therapeutic intervention for the treatment or management of a medical condition. The term encompasses a wide range of practices, including the topical application of creams or ointments, the inhalation of medications, and the administration of systemic therapies. Each application method is designed to optimize the delivery of the active ingredient to achieve the desired therapeutic effect while minimizing potential side effects.

Dosage

Children: Refer to specific drug monographs for paediatric dosing guidelines.

Adults: Refer to specific drug monographs for adult dosing guidelines.

Mechanism of action

The mechanism of action for a drug largely depends on its chemical composition and the specific condition it is intended to treat. For instance, topical medications may act locally at the site of application by binding to receptors or inhibiting enzymes, whereas systemic medications may affect multiple organ systems through various pathways, including receptor activation, enzyme inhibition, or modulation of cellular signaling.

Pharmacodynamics

Pharmacodynamics involves the study of the physiological effects of drugs and their mechanisms of action. It describes how drugs interact with cellular receptors, leading to a biochemical response. The potency and efficacy of a drug can vary based on factors such as receptor affinity, drug concentration, and the presence of other substances. The therapeutic window is also an important consideration, as it defines the range of dosages that produce therapeutic effects without causing toxicity.

Pharmacokinetics

Pharmacokinetics refers to the absorption, distribution, metabolism, and excretion (ADME) of drugs within the body. The absorption of a drug can be influenced by its formulation and the route of administration. Distribution relates to how the drug disperses throughout body tissues, which can be affected by blood flow and tissue permeability. Metabolism typically occurs in the liver, where enzymes convert the drug into active or inactive metabolites. Finally, excretion mainly occurs through the kidneys, where metabolites are eliminated via urine, although some drugs may also be excreted in feces or through sweat.

Pregnancy

Consult a healthcare provider for guidance on use during pregnancy.

Breast-feeding

Consult a healthcare provider for guidance on use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: benzoate

BNF-referenced

Benzoate is the conjugate base of benzoic acid, characterized by the molecular formula C7H5O2-. It is primarily utilized as a food preservative and has various roles in metabolic pathways within the human body. As a naturally occurring compound, it plays a role in the biosynthesis of several secondary metabolites and is involved in the degradation of certain aromatic compounds.

Indications

  • Food preservative
  • Treatment of urea cycle disorders
  • Metabolic disorders involving benzoyl-CoA

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines based on condition.

Adults: Refer to the BNF for specific dosing guidelines based on condition.

Mechanism of action

Benzoate acts mainly by inhibiting the growth of bacteria and fungi through its ability to lower the pH, creating an environment that is less favorable for microbial growth. It is also involved in metabolic pathways where it helps in the conjugation of toxic substances, facilitating their excretion from the body.

Pharmacodynamics

Benzoate is known for its antimicrobial properties, which are particularly effective against a wide range of fungi and bacteria. Its efficacy as a preservative is due to its ability to penetrate microbial cell membranes and disrupt their metabolic processes. Additionally, it has been observed to modulate various metabolic pathways, particularly those associated with aromatic compound degradation.

Pharmacokinetics

After ingestion, benzoate is rapidly absorbed in the gastrointestinal tract. It is metabolized primarily in the liver, where it undergoes conjugation with glycine to form hippurate, which is then excreted in the urine. The half-life of benzoate varies depending on individual metabolic rates but is generally short due to its efficient conversion and excretion.

Pregnancy

There is limited data on the use of benzoate in pregnancy. Consultation with healthcare professionals is advised before use.

Breast-feeding

Limited data is available on the excretion of benzoate in breast milk. Caution is recommended when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: benzyl

BNF-referenced

Benzylpenicillin, a member of the penicillin class of antibiotics, is primarily used to treat infections caused by susceptible microorganisms. It is effective against a range of Gram-positive bacteria and some Gram-negative bacteria, making it a valuable agent in the treatment of various infections, including pneumonia, meningitis, and syphilis.

Indications

  • Bacterial infections
  • Pneumonia
  • Meningitis
  • Syphilis
  • Endocarditis
  • Skin and soft tissue infections

Dosage

Children: Paediatric dosing for benzylpenicillin is determined by the child's weight and the severity of the infection. Refer to the BNF for Children for specific dosing guidelines.

Adults: The usual adult dose for benzylpenicillin varies based on the type and severity of the infection. It is generally administered via intramuscular or intravenous routes. For severe infections, doses may range from 1 to 4 million units every 4 to 6 hours.

Mechanism of action

Benzylpenicillin exerts its antibacterial effects by inhibiting the synthesis of bacterial cell walls. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, disrupting the transpeptidation process, which is crucial for cross-linking peptidoglycan layers. This inhibition leads to cell lysis and death of the bacteria.

Pharmacodynamics

Benzylpenicillin demonstrates time-dependent bactericidal activity, meaning its effectiveness is related to the duration of time the drug concentration remains above the minimum inhibitory concentration (MIC) for the target bacteria. It has a narrow spectrum of activity, primarily targeting Gram-positive cocci and some Gram-negative rods.

Pharmacokinetics

Benzylpenicillin is typically administered parenterally due to poor oral absorption. It is rapidly distributed throughout the body and can penetrate various tissues, including the central nervous system during inflammation. The drug is primarily eliminated by renal excretion, with a half-life of approximately 30 minutes to 1 hour in healthy individuals. Dosage adjustments may be necessary in patients with renal impairment.

Interactions

  • leflunomide+benzylpenicillin: Unknown (increases exposure)
  • nitisinone+benzylpenicillin: Unknown (increases exposure)
  • teriflunomide+benzylpenicillin: Unknown (increases exposure)

Pregnancy

Benzylpenicillin is generally considered safe to use during pregnancy, as it is a penicillin antibiotic and has a long history of use.

Breast-feeding

Benzylpenicillin is excreted in breast milk in small amounts, but it is not expected to have adverse effects on a nursing infant.

Storage

Store in a cool, dry place, protected from light. Reconstituted solutions should be used promptly or stored in a refrigerator and used within a limited time frame.

Formulations

  • Benzylpenicillin injection

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: benzyl

PubChem CID 123147

Molecular formula: C7H7

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.